Molecular Biomarkers of Tumors: Advancing Genetic Studies
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular Genetics and Genetic Diseases".
Deadline for manuscript submissions: 15 September 2024 | Viewed by 673
Special Issue Editors
Interests: chromosomes; human genetics; genomics; genetic analysis; DNA sequencing; sequencing DNA; medical genetics; molecular genetics; mutation
Interests: investigating the interaction of Alzheimer's disease and sleep disruption in various mouse models, including use of novel noninvasive technologies, immunohistochemistry and metabolomics
Special Issue Information
Dear Colleagues,
We invite researchers and clinicians to contribute to the Special Issue of Biomedicine, dedicated to "Molecular Biomarkers of Tumors: Advancing Genetic Studies." This Special Issue aims to explore the latest developments in the realm of molecular biomarkers, with a specific focus on genetic investigations in tumors.
In the age of precision medicine, understanding the genetic landscape of tumors is crucial for accurate diagnosis, prognosis, and treatment decisions. This Special Issue will encompass a diverse range of topics related to molecular biomarkers, such as the identification and validation of novel genetic markers in various tumor types, genomic profiling to unravel tumor heterogeneity, and the application of molecular biomarkers for early detection and personalized therapeutic approaches.
We welcome original research articles and reviews that present cutting-edge discoveries, methodologies, and clinical applications in the field of molecular biomarkers in oncology. Additionally, studies addressing the challenges of translating genetic findings into clinical practice will be highly valued.
By fostering collaboration among multidisciplinary researchers, this Special Issue aims to advance our knowledge of tumor biology and personalized medicine. Ultimately, this knowledge will contribute to the development of more effective and targeted cancer therapies, enhancing patient outcomes and overall quality of life.
Dr. Sainan Wei
Dr. Jing Di
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
